This message contains images. If you don't see images, click here to view.
Advertise in this news brief.




Text Version   RSS   Subscribe   Unsubscribe   Archive   Media Kit May 14, 2014


 

Advertisement

74 cancer care facilities receive national achievement award
Commission on Cancer
The Commission on Cancer (CoC) of the American College of Surgeons has granted its Outstanding Achievement Award (OAA) to a select group of 74 accredited cancer programs across the United States.

Established in 2004, the CoC OAA recognizes cancer programs that strive for excellence in providing quality care to cancer patients. The award is granted to facilities that demonstrate a Commendation level of compliance with seven standards that represent four areas of program management, clinical services, patient outcomes, and data quality. The level of compliance with the seven standards is determined during an on-site evaluation by a physician surveyor. In addition, facilities must receive a compliance rating for each of the remaining 27 cancer program standards. Seventy-four programs received the OAA as a result of surveys performed in 2013. This number represents approximately 14 percent of cancer programs surveyed during this period. A majority of recipients are community-based facilities; however, there were also academic hospitals, integrated networks, a pediatric facility, and a freestanding cancer center that also received this year's award.

The CoC press release announcing the 2013 OAA recipients is now online. OAA programs are also listed online.

   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


Older women may face higher risk of cervical cancer
NBC News
Women over age 65, who may believe they no longer need gynecological exams, may be at a much higher risk of cervical cancer than previously believed, researchers reported. Current guidelines are based on data that don’t take into account the high rate of hysterectomy in the U.S., the team at the University of Maryland School of Medicine found.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


HDIL-2 for kidney cancer offers cure, but needs to be given by experts
Medscape
Although high-dose interleukin-2 (HDIL-2) is currently not used often in the treatment of metastatic renal cell carcinoma (mRCC), the toxicity can be managed by expert centers, and it offers the only potentially curative treatment for patients with advanced disease. A retrospective study of 88 patients from one such center, published online on April 21 in Urology, reports that 60 percent of patients were still alive at two years, and four patients (4.5 percent) had a complete response after treatment with only HDIL-2.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


National Cancer Survivors Day
Commission on Cancer
June 1 marks the 27th Annual National Cancer Survivors Day that brings cancer survivors together to show that there is life after receiving a diagnosis of cancer. The Commission on Cancer (CoC) and the National Accreditation Program for Breast Centers (NAPBC) encourage your center to observe this day and use it as an opportunity to display/promote your CoC and/or NAPBC accreditation status. To help you promote this event within your program and the community, the CoC and the NAPBC have developed a poster that you can download and print. To access the poster, CoC-accredited programs can go to CoC Datalinks and click on the “Marketing Resources”; NAPBC-accredited centers can log into the NAPBC Portal and click “Marketing Page” under the Marketing Resources tab. For information, please contact Susan Rubin.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


Chronic inflammation may be linked to aggressive prostate cancer
Oncology Nurse Advisor
An analysis of prostate tissue biopsies collected from some participants of the placebo arm of the Prostate Cancer Prevention Trial (PCPT) found that those whose benign prostate tissue had chronic inflammation had 1.78 times higher odds of having prostate cancer, and 2.24 times higher odds of having an aggressive disease (characterized by Gleason sum of seven to 10), compared with those whose benign prostate tissue had no inflammation. This study was published in Cancer Epidemiology, Biomarkers & Prevention.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


After lung cancer surgery, what happens between 30 and 90?
Medscape
Thirty-day mortality following lung cancer surgery has greatly decreased in the United States during the past decades, and, not unexpectedly, it is lowest in high-volume hospitals, according to new research. However, the study also identified, perhaps surprisingly, that mortality after lung cancer surgery continued to increase to 90 days.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


FORDS revision project
Commission on Cancer, National Cancer Data Base
FORDS is a manual that contains all of the data items with rules and coding options for cancer registrars to collect data in their hospital registry. These data are then submitted to the National Cancer Data Base (NCDB). The data available in the NCDB come from FORDS, Collaborative Stage, and AJCC Cancer Staging Manual. The Commission on Cancer (CoC) is seeking input from registrars, data users, physicians, and others to modernize the current FORDS manual. This project kicked off in April 2014. The input will be gathered through an electronic survey, which will be open through September 2014.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Novel target found for chemotherapy-resistant leukemia cells
Medical Xpress
Researchers at Children's Hospital Los Angeles have discovered that by targeting a particular receptor, chemotherapy-resistant cancer cells can be killed in an acute form of childhood leukemia, offering the potential for a future treatment for patients who would otherwise experience relapse of their disease.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


New targets identified for relieving chemotherapy-induced pain
Oncology Nurse Advisor
Scientists have identified new pain relief targets that could be used to provide relief from chemotherapy-induced pain. This discovery occurred when scientists were researching how pain occurs in nerves in the periphery of the body. "We have been investigating and identifying mechanisms underlying pain generation, and our findings could help chemotherapy patients who suffer pain-related side effects," said Marzia Malcangio, PhD, of King's College London in the United Kingdom.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Vitamin E, selenium can greatly increase prostate cancer risk
OncLive
Despite being quite popular, the dietary supplements vitamin E and selenium do not protect men from developing prostate cancer and, in fact, greatly increase risk in certain patients if taken at doses higher than those recommended within the average diet, according to recently published results from the Selenium and Vitamin E Cancer Prevention Trial (SELECT). In men with high levels of selenium at baseline, selenium supplements increased the risk of high-grade cancer by 91 percent, investigators found.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Researchers identify genetic factors that may aid survival from brain cancer
Medical Xpress
A Henry Ford Hospital research team has identified specific genes that may lead to improved survival of glioblastoma, the most common and deadly form of cancerous brain tumor. The molecular data is expected to aid further research into genes that either help or impede the survival of patients diagnosed with the tumor, which can invade and rapidly grow in any part of the human brain.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE
 
Advertisement

Advertisement



The CoC Brief

Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Samantha Emerson, Content Editor, 469.420.2669
Contribute news

Disclaimer: The CoC Brief is a digest of the most important news selected for the American College of Surgeons Commission on Cancer from thousands of sources by the editors of MultiBriefs, an independent organization that also manages and sells advertising. The Commission on Cancer does not endorse any of the advertised products and services. Opinions expressed in the articles are those of the author and not of the American College of Surgeons and the Commission on Cancer.


Be sure to add us to your address book or safe sender list so our emails get to your inbox. Learn how.

This edition of The CoC Brief was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!

Recent issues

May 7, 2014
April 30, 2014
April 23, 2014
April 16, 2014






7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063